Endurant Capital Management LP Ptc Therapeutics, Inc. Transaction History

Endurant Capital Management LP

  • $0
  • Q1 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$38.16 - $48.86 $1.35 Million - $1.73 Million
35,361 Added 197.7%
53,247 $2.58 Million
Q4 2022

Feb 14, 2023
BUY
$33.53 - $54.79 $599,717 - $979,973
17,886 New
17,886 $682,000
Q3 2020

Nov 16, 2020
SELL
$45.41 - $57.07 $893,532 - $1.12 Million
-19,677 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$42.56 - $54.98 $837,453 - $1.08 Million
19,677 New
19,677 $998,000
Q2 2019

Aug 14, 2019
SELL
$35.42 - $45.0 $598,704 - $760,635
-16,903 Closed
0 $0
Q1 2019

May 15, 2019
BUY
$28.09 - $39.49 $474,805 - $667,499
16,903 New
16,903 $636,000

Others Institutions Holding PTCT

# of Institutions
221
Shares Held
78.1M
Call Options Held
144K
Put Options Held
58.7K
View Full List

About PTC THERAPEUTICS, INC.

PTCT Quotes by TradingView
  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $3.31B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track This Portfolio

Track Endurant Capital Management LP Portfolio

Follow Endurant Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Endurant Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Endurant Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email